The underrepresentation of ethnically diverse populations in cancer
clinical trials results in the inequitable distribution of the risks and
benefits of this research. Using a case study approach, we apply a conceptual
framework of factors associated with the participation of diverse population
groups in cancer clinical trials developed by Dr. Jean Ford and colleagues to
increase understanding of the specific strategies, and barriers and promoters
addressed by these strategies, that resulted in marked success in accrual of
racially and ethnically diverse populations in cancer clinical research. Results
indicate that the studies presented were able to successfully engage minority
participants due to the creation and implementation of multi-level, multifaceted
strategies that included: culturally and linguistically appropriate outreach,
education, and research studies that were accessible in local communities;
infrastructure to support engagement of key stakeholders, clinicians, and
organizations serving minority communities; testimonials by ethnically diverse
cancer survivors; availability of medical interpretation services; and providing
infrastructure that facilitated the engagement in clinical research of
clinicians who care for minority patient populations. These strategic efforts
were effective in addressing limited awareness of trials, lack of opportunities
to participate, and acceptance of engagement in cancer clinical trials. Careful
attention to the context and population characteristics in which cancer clinical
trials are conducted will be necessary to address disparities in research
participation and cancer outcomes. These studies illustrate that progress on
minority accrual into clinical research requires intentional efforts to overcome
barriers at all three stages of the accrual process: awareness, opportunity and
acceptance of participation.